Range of eligible clients: CDEC mentioned the uncertainty in the quantity of patients with moderately critical to severe hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical gurus consulted by CADTH indicated that some patients who're categorized as acquiring delicate or reasonable sickness may have a extreme bleeding phenotype, which https://smedleyq124kkj6.national-wiki.com/user